Reporting cases of misconduct in the context of federal science funding can be a daunting task. But mechanisms to support whistleblowers do exist.

Authorities had silenced Li Wenliang after he spoke out about the virus, now known as 2019-nCoV, in the early days of the epidemic.

The physician and researcher challenged the Chinese government over her findings of widespread hepatitis and HIV contamination during blood collection.

A government scientist, he tried to end the unethical study, was unsuccessful, and then spent his career combatting injustice in healthcare.

An agency scientist who accused the Centers for Disease Control and Prevention of suppressing disagreements over the accuracy of a diagnostic test obtains whistleblower protection.

Whistleblower “named” in PubPeer suit; African CDC; FDA oversight of dietary supplements

The moderators of the post-publication peer review forum say they could be facing their first legal case.

A former employee complains that StemCells, Inc., fired him after he blew the whistle on improper manufacturing practices that could endanger patients.

It takes significant time and money for a scientist to defend his or her accusation of research misconduct.

Dealing with anonymous misconduct allegations; efficiently generating iPSCs; distinguishing viral infections from non-viral; imaging tau in vivo

Anonymous tipsters who allege scientific misconduct can make journal editors squeamish. But should a whistleblower's identity matter?

A new analysis finds that while some federal agencies have made strides in safeguarding the validity of their research, more work needs to be done.

The author of a whistleblower blog has revealed his identity after the site was suspended due to legal threats from accused scientists.

A jury finds that UVA wrongfully fired a researcher for reporting that his supervisor altered an NIH grant budget.  

Top FDA officials, including Commissioner Margaret Hamburg, were aware the agency was monitoring staff emails discussing the safety of some approved medical devices.

The researcher who raised questions about the studies by social psychologist Dirk Smeesters flags dodgy data from another scientist.

Current and former employees of the US Food and Drug Administration have filed suit, alleging that their employer spied on them for whistleblowing.

A US-based group reviews the records of discredited researcher Andrew Wakefield to reassess whether he knowingly misrepresented results.

New draft policies for safeguarding government research from political influence—and protecting those who bring such misconduct to light—could be improved, according to advocacy groups.